BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22271072)

  • 1. Effect of 40 mg versus 10 mg of atorvastatin on oxidized low-density lipoprotein, high-sensitivity C-reactive protein, circulating endothelial-derived microparticles, and endothelial progenitor cells in patients with ischemic cardiomyopathy.
    Huang B; Cheng Y; Xie Q; Lin G; Wu Y; Feng Y; Gao J; Xu D
    Clin Cardiol; 2012 Feb; 35(2):125-30. PubMed ID: 22271072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ezetimibe on endothelial progenitor cells and microparticles in high-risk patients.
    Lins LC; França CN; Fonseca FA; Barbosa SP; Matos LN; Aguirre AC; Bianco HT; do Amaral JB; Izar MC
    Cell Biochem Biophys; 2014 Sep; 70(1):687-96. PubMed ID: 24777811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short term effects of atorvastatin on endothelial functions and oxidized LDL levels in patients with type 2 diabetes.
    Akalin A; Temiz G; Akcar N; Sensoy B
    Endocr J; 2008 Oct; 55(5):861-6. PubMed ID: 18506090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
    Kuryata OV; Yegorova YV
    Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.
    Beckman JA; Liao JK; Hurley S; Garrett LA; Chui D; Mitra D; Creager MA
    Circ Res; 2004 Jul; 95(2):217-23. PubMed ID: 15178637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients.
    Joy MS; Dornbrook-Lavender KA; Chin H; Hogan SL; Denu-Ciocca C
    Ann Pharmacother; 2008 Jan; 42(1):9-15. PubMed ID: 18000162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pitavastatin versus atorvastatin on the peripheral endothelial progenitor cells and vascular endothelial growth factor in high-risk patients: a pilot prospective, double-blind, randomized study.
    Lin LY; Huang CC; Chen JS; Wu TC; Leu HB; Huang PH; Chang TT; Lin SJ; Chen JW
    Cardiovasc Diabetol; 2014 Jul; 13():111. PubMed ID: 25027585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atorvastatin on endothelium-dependent vasodilation in postmenopausal women with average serum cholesterol levels.
    Mercuro G; Zoncu S; Saiu F; Sarais C; Rosano GM
    Am J Cardiol; 2002 Oct; 90(7):747-50. PubMed ID: 12356389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in action of atorvastatin and ezetimibe in lowering low-density lipoprotein cholesterol and effect on endothelial function: randomized controlled trial.
    Matsue Y; Matsumura A; Suzuki M; Hashimoto Y; Yoshida M
    Circ J; 2013; 77(7):1791-8. PubMed ID: 23603824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of high doses of atorvastatin on the endothelial function of the coronary arteries].
    Simaitis A; Laucevicius A
    Medicina (Kaunas); 2003; 39(1):21-9. PubMed ID: 12576762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome.
    Singh U; Devaraj S; Jialal I; Siegel D
    Am J Cardiol; 2008 Aug; 102(3):321-5. PubMed ID: 18638594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes reduces bone marrow and circulating porcine endothelial progenitor cells, an effect ameliorated by atorvastatin and independent of cholesterol.
    Mohler ER; Shi Y; Moore J; Bantly A; Hamamdzic D; Yoder M; Rader DJ; Putt M; Zhang L; Parmacek M; Wilensky RL
    Cytometry A; 2009 Jan; 75(1):75-82. PubMed ID: 19051240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
    Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
    J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of atorvastatin on circulating hsCRP concentrations: a sub-study of the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study.
    Gensini GF; Gori AM; Dilaghi B; Rostagno C; Gaw A; Blanco-Colio LM; de Teresa E; Egido J; Farsang C; Leiter LA; Martineau P; Nozza A; Langer A;
    Int J Cardiol; 2010 Jul; 142(3):257-64. PubMed ID: 19217176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients.
    Oikonomou E; Siasos G; Zaromitidou M; Hatzis G; Mourouzis K; Chrysohoou C; Zisimos K; Mazaris S; Tourikis P; Athanasiou D; Stefanadis C; Papavassiliou AG; Tousoulis D
    Atherosclerosis; 2015 Feb; 238(2):159-64. PubMed ID: 25525743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin 10 mg plus ezetimibe 10mg compared with atorvastatin 20 mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease.
    Uemura Y; Watarai M; Ishii H; Koyasu M; Takemoto K; Yoshikawa D; Shibata R; Matsubara T; Murohara T
    J Cardiol; 2012 Jan; 59(1):50-6. PubMed ID: 22100058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial dysfunction.
    See VY; DeNofrio D; Goldberg L; Chang G; Sasseen B; Kolansky DM; Pickering F; Kao A; Loh E; Wilensky RL
    Am J Cardiol; 2003 Jul; 92(1):11-5. PubMed ID: 12842237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JA; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2002 Oct; 90(7):689-96. PubMed ID: 12356379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease.
    Vasa M; Fichtlscherer S; Adler K; Aicher A; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2001 Jun; 103(24):2885-90. PubMed ID: 11413075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.